PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Calcium Lactate→

Calcium Lactate PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
814-80-2
Molecular formula
C6H10CaO6
Molecular weight
218.22 g/mol
Drug class
Inorganic calcium saltoral calcium supplement
Mechanism of action
Dissociates in the gastrointestinal tract to provide calcium ions for intestinal absorption and maintenance of normal extracellular calcium, bone mineralisation and neuromuscular function.
Indications / reported uses
  • Prevention and treatment of inadequate calcium intake and calcium deficiency as an oral supplement; use in clinically significant hypocalcaemia depends on the formulation and local product authorisation

Sources: NIH Office of Dietary Supplements — Calcium fact sheet · PubChem — Calcium lactate · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Calcium Lactate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Calcium Lactate Permitted Daily Exposure (PDE) report (the Calcium Lactate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Calcium Lactate Occupational Exposure Limit (OEL) report (the Calcium Lactate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.